GREENBELT – Republicans, reeling from the fallout of a fellow GOPer’s conduct with underage pages, are trying to tarnish Democratic candidates by taking misleading jabs at Maryland Rep
Gilchrest’s Path to Congress Leads Through Woods
WASHINGTON – On a Sunday afternoon a month before the midterm elections, most candidates scrambled to shake hands with voters and get their hands on the latest poll numbers
Democratic Challenger Energized by Widespread Discontent
ANNAPOLIS – During his years as a nursing assistant at Boston’s Beth Israel Deaconess Medical Center, Jim Corwin was always willing to roll up his sleeves and do whatever it was that needed doing — even if it meant changing bedpans
Van Hollen Continues Life on the Fast Track
WASHINGTON – The House of Representatives was in session, and Rep
^White Sees Only Success in Uphill 3rd District Run
WASHINGTON – When John White, the Republican candidate for Maryland’s 3rd Congressional District, was a high-school intern for Democratic Rep
Court Rules Immigrant Children Must Retain Health Benefits
ANNAPOLIS – The Court of Appeals Thursday ruled that about 3,000 children and pregnant woman who are recent immigrants should keep receiving health care while a lower court decides whether it is constitutional for the state to cut off their Medicaid benefits
Committee Pushes for Legislation Against Ehrlich Firing Practices
ANNAPOLIS – A special joint committee of the General Assembly Thursday approved a 135-page report that criticizes Gov
Cox Defends Ehrlich Record on Health Care
BALTIMORE – Republican lieutenant governor candidate Kristen Cox paid a visit to Mayor Martin O’Malley’s backyard Thursday, using a speaking invitation at Johns Hopkins University to defend the Ehrlich administration’s record on health care
State-Funded Researchers Required to Share Stem Cell Lines
CATONSVILLE – Scientists receiving state grants to conduct stem cell research will be required to share any stem cell lines developed using Maryland public funds with other scientists – a requirement that may deter private biotech firms looking to make a profit off new stem cell lines from applying for state research money